1. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma,J Nucl Med 1996; 37: 1428–1436.
2. Scott WJ, Shepherd J, Gambhir SS. Cost-effectiveness of FDG-PET for staging non-small-cell lung cancer: a decision analysis,Ann Thoracic Surg 1998; 66: 1876–1885.
3. Weber W, Bulow H, Romer W, Prauer H, Gambhir SS, Schwaiger M. FDG-PET in solitary pulmonary nodules: A german cost-effectiveness analysis [Abstract].J Nucl Med 1997; 38 (suppl): 245p.
4. Gambhir SS, Shepherd J, Phelps ME. A theoretical decision analysis model for the cost effectiveness of newly emerging coincidence imaging (CI) technology in the presurgical staging of non-small-cell lung carcinoma (NSCLC) [Abstract].J. Nucl Med 1997; 38 (suppl): 245p.
5. Steinert HC, von Schulthess GK, Weder W. Effectiveness of whole-body FDG PET in staging of non-small-cell lung cancer (NSCLC) [Abstract].J Nucl Med 1998; 39 (suppl): 80p.